Stockreport

Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF In the year-ago quarter, Kymera reported a loss of 90 cents per share. Collaboration revenues totaled $3.7 million, which missed the Zacks Consensus Estimate of $9 mil [Read more]